🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

C. Tilden Hagan

University of North Carolina at Chapel Hill

ORCID: 0000-0001-6640-476X

EngineeringMaterials ScienceImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models”.

Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models

Acta Biomaterialia(2021)10.1016/j.actbio.2021.02.001

N/A

0.644DataRank · unranked

72 citations

C. Tilden Hagan, Hayley Foley, Xi Tian, Feifei Yang, Kin Man Au +8 more

Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine

Bioconjugate Chemistry(2020)10.1021/acs.bioconjchem.0c00520

N/A

0.483DataRank · unranked

24 citations

Yu Mi, Nicole M. Knape, Andrew Z. Wang, C. Tilden Hagan

Continuous liquid interface production of 3D printed drug-loaded spacers to improve prostate cancer brachytherapy treatment

Acta Biomaterialia(2022)10.1016/j.actbio.2022.06.023

N/A

0.373DataRank · unranked

11 citations

Cameron J. Bloomquist, Isaiah Kim, Nicole M. Knape, James D. Byrne, Litao Tu +5 more

Emerging Nano-/Microapproaches for Cancer Immunotherapy

UNC Libraries(2024)10.17615/snkv-1209

N/A

0DataRank · unranked

0 citations

Andrew Z. Wang, Benjamin G. Vincent, C. Tilden Hagan, Yu Mi